HNHanaa Nafady-Hego

Hanaa Nafady-Hego

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hanaa Nafady-Hego has a total of 123 co-authors. Here are the top co-authors by number of shared publications:

  • Adeel Ajwad Butt

    Department of Population Health Sciences, Weill Cornell Medicine, Cornell University , New York, New York

    7 shared publications
  • Abdul-Badi Abou-Samra

    Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar

    5 shared publications
  • Moza Alishaq

    Affiliation Corporate Quality Department, Hamad Medical Corporation, Doha, Qatar

    5 shared publications
  • Asmaa Nafady

    17 Department of Clinical and Chemical Pathology, Faculty of Medicine, Qena University, Qena, Egypt

    4 shared publications
  • Jameela Ali Al Ajmi

    Affiliation Corporate Quality Department, Hamad Medical Corporation, Doha, Qatar

    4 shared publications
  • Mohamed Elgendy

    School of Medical Sciences Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia, usm.my

    4 shared publications

Latest Publications

  • Open Access

    Immunophenotypic Profiling of Lymphocyte Subsets in Children and Adolescents With Acute Lymphoblastic Leukaemia: Immune Dysregulation Before and After Remission

    by Hanaa Nafady-Hego, Arwa Flemban, Saeed Kabrah, Hanan M. Abd Elmoneim, Enas Aly, Mohamed Elgendy, Talat Albukhari, Hams Alaa, Ruba Almaghrabi, Samar N. Ekram, et al.

    Background: Acute lymphoblastic leukaemia (ALL) in children is often associated with immune dysfunction, including alterations in regulatory T cells (Treg), impaired T‐cell activation, and disrupted natural killer (NK) cell function. ALL comprises immunophenotypically heterogeneous entities, primarily B‐cell ALL (B‐ALL) and T‐cell ALL (T‐ALL). However, the dynamics of Treg subsets and their relationship with broader immune alterations across treatment stages remain insufficiently characterised. Methods: In this prospective case–control study, peripheral blood samples were analysed from 31 children with newly diagnosed ALL (pre‐remission), 20 patients in remission and 24 healthy controls (HCs). Multiparameter flow cytometry was used to assess T‐cell receptor (TCR) αβ + /γδ + T cells, CD4 + /CD8 + T‐cell subsets, B cells, NK and NKT‐cell populations, CD69 activation markers, and classical and memory Treg subsets. Results: At diagnosis, patients showed significant reductions in TCR αβ + and γδ + T cells, CD4 + T‐helper cells and CD69 activation, alongside increased CD8 + T cells and NKT cells. Classical and memory Treg cells were significantly expanded in the pre‐remission group. Following remission, TCR expression and CD3 + T‐cell frequencies approached levels observed in HCs, and CD4 + CD69 + activation improved. However, CD56 bright NK cells remained reduced, and B‐cell depletion persisted in both ALL groups. Conclusion: Paediatric ALL is characterised by marked immune dysregulation involving expanded Treg populations and impaired lymphocyte activation. Although partial immune recovery occurs after remission (AR), persistent abnormalities in NK‐cell and B‐cell compartments suggest incomplete immune reconstitution.

  • Open Access

    Gastrointestinal illness among attendees of the FIFA Football World Cup 2022 in Qatar

    by Sherin Shams, Thoraya Alyafei, Hanaa Nafady-Hego, Emad Bashier Ibrahim Elmagboul, Aimon B. Malik, Anil G. Thomas, Samah Saleem, Zain Bhutta, Atika Jabeen, Muna Almaslamani, et al.


  • Open Access

    Azithromycin use before and during the COVID- 19 pandemic and the impact of implementing national evidence-based guidelines in Qatar

    by Adeel A. Butt, Sherin Shams, Hanaa Nafady-Hego, Zain Bhutta, Atika Jabeen, Aimon B. Malik, Anil G. Thomas, Samah Saleem, Aftab M. Azad, Muna Almaslamani, et al.


  • Open Access

    Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar

    by Jameela A. Al Ajmi, Aimon B. Malik, Hanaa Nafady-Hego, Fathima Hanana, Joji Abraham, Humberto G. Garcell, Ghada Hudaib, Walid Al-Wali, Faiha Eltayeb, Sherin Shams, et al.

    Background: We investigated the spectrum of infection and risk factors for invasive fungal disease due to Candida auris (CA) in Qatar. Methods: We performed structured chart reviews on individuals with any positive CA culture between May 2019 and December 2022 at three tertiary care hospitals in Qatar. Invasive CA disease (ICAD) was defined as a positive sterile site culture, or any positive culture for CA with appropriate antifungal prescription. Main outcomes included proportion of individuals who developed ICAD among those with positive cultures, and 30-day/in-hospital mortality. Results: Among 331 eligible individuals, median age was 56 years, 83.1% were male, 70.7% were non-Qataris, and 37.5% had ≥ 3 comorbidities at baseline. Overall, 86.4% were deemed to have colonization and 13.6% developed ICAD. Those with ICAD were more likely to have invasive central venous or urinary catheterization and mechanical ventilation. Individuals with ICAD had longer prior ICU stay (16 vs 26 days, P = 0.002), and longer hospital length of stay (63 vs. 43 days; P = 0.003), and higher 30-day mortality (38% vs. 14%; P.001). In multivariable regression analysis, only mechanical ventilation was associated with a higher risk of ICAD (OR 3.33, 95% CI 1.09–10.17). Conclusion: Invasive Candida auris Disease is associated with longer hospital stay and higher mortality. Severely ill persons on mechanical ventilation should be especially monitored for development of ICAD.


  • Open Access

    SARS-CoV-2 infection in 3,241 School working staffs: Impact of SARS CoV-2 variants of concern [Wild, B.1.1.7 and Omicron]

    by Moza Alishaq, Jameela Ali Al Ajmi, Mohammed Shaheen, Mohamed Elgendy, Suni Vinoy, Anil George Thomas, Sam Joseph, Tintu Elizabeth Mathew, Renjith Joseph, Christymol Thomas, et al.

    Background: There is debate over whether physical attendance at school affects the spread of the SARS-CoV-2 pandemic. Methods: A cohort of personnel from several schools in Qatar provided nasopharyngeal swabs (NPS) for SARS-CoV-2 RT-PCR and rapid antigen testing. Each of them was monitored for infection until February 2022. Results: In total, 3,241 employees gave samples for analysis. Prior to the start of the 2020–2021 academic year (Group I), 3.49% of samples tested positive for SARS-CoV-2. Most of the positive PCR results were from male, senior, non-teaching staff members. Only 110 (3.39%) employees who had enrolled in face-to-face instruction before the B.1.1.7 variant’s emergence (Group II), 238 (7.34%) after the B.1.1.7 variant’s emergence (Group III), and 410 (12.65%) after the introduction of the Omicron variant (Group IV) had reported infection by PCR test. Most people who tested positive by PCR after enrolling in school were young, female teachers. In the Cox Proportional-Hazards Model, exposure to a confirmed case, the presence of symptoms in the two weeks prior to exposure in all groups—young age in Groups II and III, male gender in Groups I and IV, shared housing in Group III, and the presence of comorbidities in Groups II and III independently predicted SARS-CoV-2 infection in school staff. Conclusion: Critical information about the risk of SARS-CoV-2 infection in school workers during the whole pandemic is provided by our study. School operations in Qatar were made safer through initial and ongoing screenings, as well as widespread vaccination of school personnel.


  • Open Access

    Risk factors influence the arterial line patency in ICU-bound patients during COVID-19 pandemic: An observational cohort study

    by Hamed Elgendy, Adel Ganaw, Vipin Kumari, Vijay Settu, Prem Chandra, Hanaa Nafady-Hego, Mohamad Hilani, Hesham Ismail, Mohamed Elkateeb

    There were increased claims of thrombotic events in ICU-bound patients with COVID-19. We designed this observational study to examine implementation of systemic anti-coagulation on arterial cathete...


  • Open Access

    Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP

    by Heba Ahmed Osman, Hanaa Nafady-Hego, Khalid Ali Nasif, Heba A Ahmed, Ekram Abdel-Rahman Mahmoud, Noher Mohamad Abass, Amal Rayan, Marwa Ahmed Mahmoud, Asmaa Nafady

    Introduction: HCC is frequently diagnosed late, when only palliative treatment is available. So, we try to use different immunological markers to identify early HCC in patients with unremarkable raised AFP. Methods: This study was conducted on 112 participants divided into two equal groups: Group I, 56 patients with liver cirrhosis and different stages of HCC; Group II, 56 patients with liver cirrhosis. The diagnosis of HCC was based on AASLD guidelines. TNM and BCLC classification systems are used for staging of HCC. Results: A significant reduction in the median percentage of lymphocyte subset (CD3+, CD4+, CD8+, CD19+) and NK cell percentage (CD56+) has been detected in HCC patients (all P < 0.001). In the HCC group the median monocyte subpopulations CD14+ CD16− Classical, CD14++ CD16+ Intermediate, and CD14−+ CD16++ Non-Classical were 11.7, 4.0, and 3.5, respectively, with marked reduction compared with liver cirrhosis group (all P < 0.001). Patients with advanced stages (BCLC C and D) were more likely to have significantly higher median CD33+ than patients with early stages (BCLC A and B) (P = 0.05); also, the median levels of HLA DR+ lymphocytes % in the HCC case group were 21.8 in patients with advanced disease (BCLC C and D) and 13.1 in patients with early stages of the disease (P = 0.04). Patients with late stage (TNM III) were more likely to have significantly higher median CD14+ CD16− Classical monocyte subset, CD36+ HLA DR+, and CD36+ CD16− than patients with early stages (TNM I and II). Conclusion: Patients with HCC with unremarkable raised AFP showed marked reduction in lymphocytes, natural killer cells, and all monocyte subpopulations. In addition, patients with advanced HCC showed increased CD33+ and HLA DR+ lymphocytes %, CD14+ CD16− Classical monocyte subset, CD36+ HLA DR+, and CD36+ CD16− compared with patients with early stages of HCC.


  • Open Access

    Increased percentage of apoptotic and CTLA-4 (CD152) expressing cells in CD4+/CD8+ cells in COVID-19 patients

    by Asmaa M. Zahran, Hanaa Nafady-Hego, Alaa Rashad, Omnia El-Badawy, Khalid Ali Nasif, Amr Talat Mostafa, Heba Ahmed Osman, Eptehal Mohammed Dongol, Abdelkader Ahmed Hashim, Ghada M. Abdelrazek, et al.

    Coronavirus infectious disease 2019 (COVID-19) confirmed cases are characterized by T lymphopenia. Total apoptotic and cytotoxic T-lymphocyte antigen-4 (CTLA-4) expressing cells among CD4+/CD8+ cells were analyzed in 24 COVID-19 patients (16 out-patients and 8 in-patients) and 18 healthy volunteers using flow cytometry to detect their possible role in T lymphopenia. Hospitalized patients did not show significant difference compared to non-hospitalized patients. While the percentage and absolute count of CD4+/CD8+ cells were significantly reduced in COVID-19 cases compared to healthy control (P < .05), the proportion of apoptotic and CTLA-4 expressing CD4+/CD8+ cells were significantly up-regulated in COVID-19 patients (P < .05). In addition, apoptotic and CTLA-4+/CD4+ cells were directly related to dyspnea duration, chest CT score, ferritin, and C-reactive protein and inversely correlated with platelet count in COVID-19 patients. While apoptotic and CTLA-4+/CD8+ cells were directly related to lymphocyte count in COVID-19 patients. The apoptotic and CTLA-4+ cells were directly related to each other in CD4+/CD8+ cells (P < .05). White blood cells (WBCs) (×103/L), eosinophils (ratio and count), lymphocyte ratio, neutrophil ratio, neutrophil/lymphocyte ratio, neutrophil/CD4 ratio, neutrophil/CD8 ratio, CD4+ cells ratio, and CTLA-4+ cells percentage), and CD8+ cells (ratio, count, total apoptotic cell, and CD152 + cells) were all found to be significantly altered in association with COVID-19. Total lymphopenia and depletion of CD4+/CD8+ cells are characterizing COVID-19 patients. Increased apoptosis and CTLA-4 expression in CD4+/CD8+ cells in COVID-19 and their correlations with reduced cell count and severity indicators as CRP and ferritin can be used for diagnosis and follow up of the clinical severity. Our current study proposes promising future diagnostic and therapeutic targets.


  • Open Access

    Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions

    by Moza Alishaq, Hanaa Nafady-Hego, Andrew Jeremijenko, Jameela Ali Al Ajmi, Mohamed Elgendy, Naser Ali Asad Al Ansari, Hamed Elgendy, Abdul-Badi Abou-Samra, Adeel A Butt

    Objective: To determine the prevalence of SARS-CoV-2 virus infection among female workers who were restricted to working from home compared with those who continued to attend in-person work. Methods: As part of national surveillance program, serum samples for SARS-CoV-2 antibody testing and nasopharyngeal swabs for SARS-CoV-2 PCR were obtained on 1636 female school staff and salon/spa workers who were restricted to work remotely (restricted group) and 1190 female health-care workers who continued in-person work (unrestricted group). Results: Seropositivity rate was 5.1% among the restricted and 22.7% among the unrestricted group (P < 0.0001). Presence of symptoms at baseline (adjusted odds ratio [aOR], 2.88; 95% CI 2.09– 3.97), contact with a confirmed case (aOR 2.34; 95% CI 1.37– 3.98), and unrestricted work type (aOR 4.71; 95% CI 3.24– 6.86) were associated with a higher risk of infection, while increasing age was associated with a lower risk of infection. Conclusion: Prevalence of SARS-CoV-2 infection as determined by seropositivity was higher among women who were not subject to workplace restrictions.


  • Open Access

    Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker (vol 10, a1296, 2021)

    by Asmaa M. Zahran, Hanaa Nafady-Hego, Sawsan M. Moeen, Hanan A. Eltyb, Mohammed M. Wahman, Asmaa M. Nafady

    The African Journal of Laboratory Medicine focuses on the role of the laboratory and its professionals in the clinical and public healthcare sectors, and is specifically based on an African frame of reference.